An open-label, randomized, multicenter, steady-state bioequivalence study of paliperidone palmitate extended-release injectable suspension in subjects with schizophrenia

Neuroscience Applied 2026 Open access

Read full text

Authors: Ofer Agid, A. Shaw, J.C. Gorski, M.S. Liu, P.C. Ganapathi, S. Hegde, M.M. Toro, F. Michael, K. Subramaniam, Pradeep Purushottamahanti

DOI: 10.1016/j.nsa.2025.106837

Cited by: 0

Fields of Study & Subjects

Schizophrenia research and treatment Diabetes Management and Research Botulinum Toxin and Related Neurological Disorders